Open access · CC-BY
via OpenAlex
Curculigoside Ameliorates Bone Loss by Influencing Mesenchymal Stem Cell Fate in Aging Mice
Na Wang, Ziyi Li, Shilun Li, Yukun Li, Liu Gao, Xiaoxue Bao, Ke Wang, Chang Liu, Peng Xue, Sijing Liu
Frontiers in Cell and Developmental Biology · 2021 · ▲ 13 citations
Abstract
Senile osteoporosis is characterized by increased bone loss and fat accumulation in marrow. Curculigoside (CCG) is the major bioactive component of Curculigo orchioides, which has been used as anti-osteoporosis therapy for elder patients since antiquity. We aimed to investigate the underlying mechanisms by which CCG regulated the bone-fat balance in marrow of aging mice. In our study, CCG treatment was identified to interfere with the stem cell lineage commitment both in vivo and in vitro . In vivo , CCG promoted the transcriptional co-activator with PDZ-binding motif (TAZ) expression to reverse age-related bone loss and marrow adiposity. In vitro , proper concentration of CCG upregulated TAZ expression to increase osteogenesis and decrease adipogenesis of bone marrow mesenchymal stem cells (BMSCs). This regulating effect was discounted by TAZ knockdown or the use of MEK-ERK pathway inhibitor, UO126. Above all, our study confirmed the rescuing effects of CCG on the differential shift from adipogenesis to osteogenesis of BMSCs in aging mice and provided a scientific basis for the clinical use of CCG in senile osteoporosis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fcell.2021.767006
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Wang, N., Li, Z., Li, S., Li, Y., Gao, L., Bao, X., Wang, K., Liu, C., Xue, P., & Liu, S. (2021). Curculigoside Ameliorates Bone Loss by Influencing Mesenchymal Stem Cell Fate in Aging Mice. <em>Frontiers in Cell and Developmental Biology</em>. https://doi.org/10.3389/fcell.2021.767006
Vancouver
Wang N, Li Z, Li S, Li Y, Gao L, Bao X, et al. Curculigoside Ameliorates Bone Loss by Influencing Mesenchymal Stem Cell Fate in Aging Mice. Frontiers in Cell and Developmental Biology. 2021. doi:10.3389/fcell.2021.767006.
BibTeX
@article{na2021Curcul,
title = {Curculigoside Ameliorates Bone Loss by Influencing Mesenchymal Stem Cell Fate in Aging Mice},
author = {Na Wang and Ziyi Li and Shilun Li and Yukun Li and Liu Gao and Xiaoxue Bao and Ke Wang and Chang Liu and Peng Xue and Sijing Liu},
journal = {Frontiers in Cell and Developmental Biology},
year = {2021},
doi = {10.3389/fcell.2021.767006},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Elsevier eBooks 2018
Citation only
Aging of Human Mesenchymal Stem Cells
Figshare 2026
Preprint · CC-BY
SHED-derived exosomes ameliorate age-related osteoporosis by activating mitophagy in senescent bone marrow mesenchymal stem cells
Nanomedicine 2026
Preprint · OA
SHED-derived exosomes ameliorate age-related osteoporosis by activating mitophagy in senescent bone marrow mesenchymal stem cells
Bone 2014
Citation only
Characterization of bone marrow-derived mesenchymal stem cells in aging
Transfusion Medicine and Hemotherapy 2008
Open access · OA
Changes of the Functional Capacity of Mesenchymal Stem Cells due to Aging or Age-Associated Disease – Implications for Clinical Applications and Donor Recruitment
Stem Cells 2013
Open access · OA